CIK: 1532219 - Address: C/O Generation Bio Co., 301 Binney St, Cambridge, MA 02142
39 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret11141-8-53-270-17
P%wins10010000040

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/5/23 16:30
12/1/23
GBIOGeneration Bio Co.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.MADP1251.41088121161D
3/18/22 06:46
3/16/22
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP1882.3408011817D
3/15/22 18:32
3/11/22
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP.m2811.94014524740D
12/13/21 20:39
12/9/21
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP.m1993.7105410595D
5/4/20 07:30
4/30/20
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP7844.75016544538D
10/7/19 16:09
10/4/19
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOM.d1156.280185372D
6/14/19 17:22
6/12/19
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP.m1966.1603210354D
5/22/19 16:55
5/20/19
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP.m1806.770279322D
5/17/19 17:04
2/15/19
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP.m1266.750197295D
2/8/19 16:15
2/6/19
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOM.d546.18093276D
12/10/18 17:40
2/15/18
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOP.dm217.05031268D
12/10/18 17:40
12/7/18
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOP,CEOM.d7524.370172179268D
7/16/18 09:04
7/12/18
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOInterim M.d2636.760397293D
7/13/18 09:05
7/11/18
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOInterim M.d185.4603754D
2/20/18 16:36
2/15/18
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOInterim M.d835.460154351D
12/8/17 19:06
12/6/17
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDOInterim P.m414.96083135D
12/5/17 21:04
12/1/17
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn Anthony G.TXDP.m834.8601717127D
4/12/16 17:10
4/12/16
AGLEAeglea Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsQuinn AnthonyTXDP10010.00810New10D41-8-53-27
4/29/15 17:28
4/27/15
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,M.d171.700106D
4/29/15 17:28
4/27/15
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,S.d-1,100110.000-10-646D
4/23/15 19:28
4/21/15
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,S-1,080108.000-10-646D
4/17/15 17:14
4/15/15
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,M.d40740.7401017716D
4/17/15 17:14
4/15/15
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,S.d-1,050105.000-10-3916D
4/8/15 18:35
4/6/15
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,M.d22811.6902016D
4/8/15 18:35
4/6/15
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,S.d-2,76693.760-30-6516D
9/4/14 17:21
9/2/14
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,M.d23023.000106426D
9/4/14 17:21
9/2/14
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,S.d-70170.140-10-2826D
4/3/14 21:56
4/1/14
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,M.d100.95000106426D
4/3/14 17:56
4/1/14
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,M.d24011.9802018131D
4/3/14 17:56
4/1/14
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOEVP,CMO,S.d-1,67183.530-20-3931D
1/23/13 17:05
1/18/13
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieM.d90.95000916915D
1/23/13 17:05
1/18/13
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieS.d-47350.080-9-3915D
1/18/13 17:00
1/16/13
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieM.dm10.950001415D
1/18/13 17:00
1/16/13
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieS.dm-27850.070-6-2715D
7/30/12 16:50
7/26/12
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieM.dm70.9500086020D
7/30/12 16:50
7/26/12
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieS.dm-37750.200-8-2720D
7/23/12 17:10
7/19/12
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieM.dm20.9500031420D
7/23/12 17:10
7/19/12
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieS.dm-12550.000-3-1120D
6/27/12 17:25
6/25/12
GEVASynageva Biopharma CorpDEHealthBioPrdBiological Products, (No DiagQuinn AnthonyMAOSVP,ChieS-1,05740.650-26-5620D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact